| Product Code: ETC8455466 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Myanmar Lumasiran Market Overview |
3.1 Myanmar Country Macro Economic Indicators |
3.2 Myanmar Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Myanmar Lumasiran Market - Industry Life Cycle |
3.4 Myanmar Lumasiran Market - Porter's Five Forces |
3.5 Myanmar Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Myanmar Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Myanmar Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Myanmar Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Myanmar Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Myanmar Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Myanmar Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of RNA interference (RNAi) technology in Myanmar's healthcare sector |
4.2.2 Rising prevalence of rare diseases such as primary hyperoxaluria type 1 (PH1) driving the demand for innovative treatments like lumasiran |
4.2.3 Government initiatives to improve access to advanced healthcare technologies and treatments |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Myanmar may hinder the distribution and administration of lumasiran |
4.3.2 High cost associated with lumasiran treatment may limit its affordability for a significant portion of the population |
5 Myanmar Lumasiran Market Trends |
6 Myanmar Lumasiran Market, By Types |
6.1 Myanmar Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Myanmar Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Myanmar Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Myanmar Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Myanmar Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Myanmar Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Myanmar Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Myanmar Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Myanmar Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Myanmar Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Myanmar Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Myanmar Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Myanmar Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Myanmar Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Myanmar Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Myanmar Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Myanmar Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Myanmar Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Myanmar Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Myanmar Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Myanmar Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Myanmar Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Myanmar Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Myanmar Lumasiran Market Import-Export Trade Statistics |
7.1 Myanmar Lumasiran Market Export to Major Countries |
7.2 Myanmar Lumasiran Market Imports from Major Countries |
8 Myanmar Lumasiran Market Key Performance Indicators |
8.1 Number of healthcare facilities adopting RNAi technology in Myanmar |
8.2 Patient enrollment in clinical trials for lumasiran in Myanmar |
8.3 Number of healthcare professionals trained in administering lumasiran |
8.4 Government funding allocated towards rare disease treatments in Myanmar |
8.5 Number of collaborations between pharmaceutical companies and healthcare providers for lumasiran distribution and accessibility |
9 Myanmar Lumasiran Market - Opportunity Assessment |
9.1 Myanmar Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Myanmar Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Myanmar Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Myanmar Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Myanmar Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Myanmar Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Myanmar Lumasiran Market - Competitive Landscape |
10.1 Myanmar Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Myanmar Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here